Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-29

Clinical Trial Update: IVM Alone vs ALB + IVM Against Onchocerciasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ivermectin alone versus albendazole plus ivermectin for onchocerciasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Onchocerciasis | Phase 3 | Status: COMPLETED